American Journal of Cardiovascular Drugs

, Volume 17, Issue 6, pp 421–423 | Cite as

Acknowledgement to Referees

Acknowledgement to Referees

Dear Reader,

As we reach the final issue of the American Journal of Cardiovascular Drugs for 2017, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.

2017 was a successful year for the American Journal of Cardiovascular Drugs: 42 articles have been published and, as of the end of September, 15 of these had been downloaded over 300 times from the journal home page on SpringerLink. The five most downloaded articles this year (downloaded over 1000 times each) have been:

The Real Role of β-Blockers in Daily Cardiovascular Therapy

Dézsi CA, Szentes V


Clinical Pharmacology and Cardiovascular Safety of Naproxen

Angiolillo DJ, Weisman SM


Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners

Drozd M, Jankowska EA, Banasiak W, Ponikowski P


Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study

Núñez-Cortés JM, Amenós AC, Ascaso Gimilio JF, Alonso VB, Fuster VP, Pedro-Botet Montoya JC, Sala XP, Cumplido AS


Results of an International Postmarketing Surveillance Study of pl-VEGF165 Safety and Efficacy in 210 Patients with Peripheral Arterial Disease

Deev R, Plaksa I, Bozo I, Isaev A


The quality of articles published in the journal is also reflected in its most recent impact factor (2.768). Based in this impact factor, the American Journal of Cardiovascular Drugs is ranked 54th among 126 journals in the ‘Cardiac & Cardiovascular Systems’ category.

Other journals in the Adis Premier Journals Portfolio ( continue to prosper, and this year has seen the successful launch of PharmacoEconomics—Open, the newest journal in the portfolio. The journal has published a full volume of 30 articles in its first year, plus many more online first. Following in the steps of Adis’ flagship subscription journal in the field, PharmacoEconomics, the new open-access journal focuses on cost and health outcomes associated with drugs, devices and other healthcare interventions.

We thank the authors who have contributed articles to the American Journal of Cardiovascular Drugs over the course of 2017. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for the American Journal of Cardiovascular Drugs in the last 12 months:

Dimitrios Alexopoulos, Greece

Tetsuya Amano, Japan

Shailendra Anoopkumar-Dukie, Australia

Ozan O. Balkanay, Turkey

Manisha Balwani, USA

Maciej Banach, Poland

Geoffrey D. Barnes, USA

Monika Bartekova, Slovakia

Christian-Alexander Behrendt, Germany

Svetlana Blitshteyn, USA

Michael Boehm, Germany

Michael B. Bottorff, USA

Alexandros Briasoulis, USA

Diana I. Brixner, USA

Daniel Bromage, UK

Nathan Brunner, Canada

Eduardo Carracedo-Martínez, Spain

Ilaria Cavallari, Italy

Yi-Jen Chen, Taiwan

Elizabeth Yu Chiao, USA

Antonio Cittadini, Italy

Zachary L. Cox, USA

Ernesto Dalli, Spain

Mark D. Danese, USA

Renato De Vecchis, Italy

Csaba A. Dézsi, Hungary

Kathleen A. Fairman, USA

Alexander C. Fanaroff, USA

Francesco Franchi, USA

Robert Fuerst, Germany

Karla I. Galaviz, USA

Alexander S. Gallus, Australia

Raffaele Giubbini, Italy

Gustavo Goldenberg, Canada

Karen M. Goldstein, USA

Kendra J. Grubb, USA

Robert M. Hamilton, Canada

Sebastien Hascoet, France

Timothy D. Henry, USA

Inmaculada Hernandez, USA

Francisco J. Hidalgo, Spain

Daniel E. Hilleman, USA

Hirofumi Hioki, Japan

John D. Horowitz, Australia

Gerard K. Hovingh, The Netherlands

Po-Hsun Huang, Taiwan

Taku Inohara, Japan

Olivia K. Irby, USA

Dorothea Jenkins, USA

Sanjay Kalra, India

Daisuke Kamimura, USA

Aditya Kapoor, India

Kenneth A. Kellick, USA

David M. Kerins, Ireland

Marcus E. Kleber, Germany

Richard Kones, USA

K.M. Prasanna Kumar, India

Jean-Daniel Lalau, France

Gaetano A. Lanza, Italy

George Lazaros, Greece

Yannick Le Manach, Canada

Ju-Yeun Lee, Republic of Korea

Nicola L. Liberato, Italy

Gary D. Lopaschuk, Canada

Milan Macek Jr., Czech Republic

Kevin C. Maki, USA

Carlos D. Malvestutto, USA

Athanasios J. Manolis, Greece

Matteo Manuelli, Italy

Emil Martin, USA

Marian McDonagh, USA

Li-yan Miao, China

Jesús Millán, Spain

Naoki Misumida, USA

Toru Miyoshi, Japan

Mohapradeep Mohan, UK

Abdul Momen, Bangladesh

Markku S. Nieminen, Finland

Ilkay E. Orhan, Turkey

Akhil Parashar, USA

Chetan D. Patel, India

George P. Patrinos, Greece

Susanne B. Pedersen, Denmark

Pammla Petrucka, Canada

Satish R. Raj, Canada

Eva R. Rasmussen, Denmark

Eliana Reyes, UK

Haris Riaz, USA

Emilio Ros, Spain

Robert S. Rosenson, USA

Eli M. Roth, USA

Terence E. Ryan, USA

Luigi Sacca, Italy

Paulo C.J.L. Santos, Brazil

Luis Sargento, Portugal

Gianluigi Savarese, Sweden

Christian Schoergenhofer, Austria

Sabino Scolletta, Italy

Naman Shastri, India

Yon Hee Shim, Republic of Korea

Chad Slawson, USA

Alexandre A.S.M. Soares, Brazil

Claudia Spies, Germany

Steven D. Stovitz, USA

H. Robert Superko, USA

Karl Swedberg, Sweden

Hitoshi Takano, Japan

Udaya S. Tantry, USA

Hagai Tavori, USA

Dimitris Tousoulis, Greece

Stella Trompet, The Netherlands

Alexey Tsyganov, The Russian Federation

Frans Van de Werf, Belgium

Christopher Wilcox, USA

Oliver C. William Jr., USA

In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

A. Michael Lincoff, Cleveland, OH, USA [Consulting Editor]

Balram Bhargava, New Delhi, India

Deepak L. Bhatt, Boston, MA, USA

John P. Cooke, Houston, TX, USA

Prakash C. Deedwania, Fresno, CA USA

Naranjan S. Dhalla, Winnipeg, MB, Canada

Phillip A. Erwin, South Miami, FL, USA

Arthur M. Feldman, Philadelphia, PA, USA

Valentin Fuster, New York, NY,USA

Xavier Girerd, Paris, France

Sidney Goldstein, Detroit, MI, USA

Joseph A. Hill, Dallas, TX, USA

Gowraganhalli Jagadeesh, Silver Spring, MD, USA

Neal S. Kleiman, Houston, TX, USA

Antoine Lafont, Paris, France

Thierry H. Le Jemtel, New Orleans, LA, USA

Frans H.H. Leenen, Ottawa, ON, Canada

Mario Marzilli, Pisa, Italy

Venu Menon, Cleveland, OH, USA

Gilles Montalescot, Paris, France

Doralisa Morrone, Pisa, Italy

Stephen J. Nicholls, Adelaide, SA, Australia

Ali Oto, Ankara, Turkey

Bertram Pitt, Ann Arbor, MI, USA

Silvia G. Priori, Pavia, Italy

C.Venkata S. Ram, Dallas, TX, USA

Gianpaolo Reboldi, Perugia, Italy

Gaetano Santulli, New York, NY, USA

Johanne Silvain, Paris, France

Kewal K. Talwar, New Delhi, India

Michal Tendera, Katowice, Poland

Udho Thadani, Oklahoma City, OK, USA

Alec Vahanian, Paris, France

George W. Vetrovec, Richmond, VA, USA

Michael A. Weber, New York, NY, USA

William S. Weintraub, Newark, DE, USA

Harvey D. White, Auckland, New Zealand

Nathan D. Wong, Irvine, CA, USA

We do hope that you have found the articles published throughout the year in the American Journal of Cardiovascular Drugs to be interesting and informative. The editorial schedule for 2018 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.

With best wishes,

Amitabh Prakash

Editor, American Journal of Cardiovascular Drugs

Copyright information

© Springer International Publishing AG, part of Springer Nature 2017

Personalised recommendations